UPDATE 1-U.S. FDA approves oral diabetes drug from Novo Nordisk

The U.S. Food and Drug Administration on Friday approved an oral version of Novo Nordisk’s diabetes drug semaglutide, a boost for the Danish drugmaker which hopes to…… Read more “UPDATE 1-U.S. FDA approves oral diabetes drug from Novo Nordisk”